According to a comprehensive report by TechSci Research titled “Bioprocess Containers Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028,” the global Bioprocess Containers market is expected to witness remarkable growth during the forecast period of 2024-2028. This growth can be attributed to the increasing prevalence of cancer and immunological disorders, which necessitate the use of vaccines and biologics. Additionally, there is a growing preference for immunotherapy and chemotherapy in the treatment of these conditions. Furthermore, the rising global biopharmaceutical research and development activities are expected to drive the market’s growth over the forecast period. Technological advancements also play a significant role in propelling market growth. Major companies operating in the bioprocess container market are focused on providing advanced products to meet the rapidly changing industry demand and strengthen their market position, thereby further driving market growth. Moreover, the growing improvement in production yields and efficiency of bioprocess containers enables production operations at smaller scales, thereby creating increased demand for bioprocess containers in the market.
Browse over XX market data Figures spread through xx Pages and an in-depth TOC on “Bioprocess Containers Market.” – https://www.techsciresearch.com/report/bioprocess-containers-market/15113.html
Challenges and Market Segmentation
However, issues related to leachables and extractables during manufacturing are expected to hinder market growth during the forecast period. Additionally, the use of multiple materials in the production of bioprocess containers, which requires extra efforts to separate different products, may further restrain market growth.
Market Segmentation Based on Container Type
The global Bioprocess Containers market can be segmented based on the type of containers, application, end user, and region. In terms of container type, the market can be divided into the following segments:
- 2D Bioprocess Containers
- 3D Bioprocess Containers
- Other Containers and Accessories
The 2D Bioprocess Containers segment dominated the market in 2022 and is expected to maintain its dominance throughout the forecast period. This dominance can be attributed to the growing demand for bioprocess containers in the biopharmaceutical industry, particularly for research and development purposes. Furthermore, the increasing need to expedite the biopharmaceutical production process and facilitate sampling, harvest, storage, and transport of bulk intermediate products is expected to drive market growth in this segment.
Market Segmentation Based on End Users
Based on end users, the market is further segmented into the following categories:
- Biopharmaceutical Companies
- Life Science R&D Companies
- Others
The Life Science R&D Companies segment is expected to dominate the market during the forecast period. This can be attributed to the growing number of biotechnology and contract research organizations (CROs) across the globe. Additionally, the increasing number of research projects in the pharmaceutical sector and the rising inclination toward outsourcing research and manufacturing activities are expected to drive the demand for bioprocess containers in this segment.
The global Bioprocess Containers market is poised for impressive growth, driven by the increasing prevalence of cancer and immunological disorders. The market is further supported by the growing biopharmaceutical research and development activities and technological advancements. However, challenges related to manufacturing processes and the use of multiple materials in bioprocess containers may hamper market growth. The market segmentation based on container type emphasizes the dominance of 2D Bioprocess Containers, fueled by their high demand in the biopharmaceutical industry. Similarly, the Life Science R&D Companies segment is expected to dominate the market in terms of end users due to the growing number of biotechnology and CRO companies, as well as the outsourcing trend in the pharmaceutical sector.
Major companies operating in the global Bioprocess Containers market are:
- Thermo Fisher Scientific Inc.
- Cytiva Europe GmbH.
- Saint-Gobain Group.
- Lonza Group AG.
- Avantor Funding Inc.
- Merck KGaA.
- Sartorius AG.
- CellBios Healthcare and Lifesciences Pvt Ltd.
- Cole-Parmer Instrument Co.
- Biomass Ventures Pte Ltd.
Sep-2021, Thermo Fisher Scientific expanded its geographical footprint by establishing a facility in Wilson County. This facility would produce bioprocess containers and fluid transfer assemblies, which are utilized across the world by biopharma companies to make and produce therapeutics & vaccines.
Jun-2021, Avantor took over RIM Bio, manufacturer of Single-Use BioProcess Containers. This acquisition aimed to expand the company’s footprint in China and better serve bioproduction customers in the Asia Pacific and Middle East region.
Feb-2021, Thermo Fisher unveiled centrifugation BioProcess Container for closed-system handling of critical sterile liquids. Integrated with Thermo Fisher’s top centrifugation technology, the latest CentriPAK BPC is designed to overcome various challenges, providing a next-generation centrifuge container and space-saving solution.
Download Free Sample Report
Customers can also request for 10% free customization on this report.
“North America is expected to dominate in the Global Bioprocess Containers market on account of to the growing demand for biologics and growing production of vaccines using single use disposable technology across the region. Similarly, growing demand for affordable and sustainable single use bioprocess technology are the major factors which are expected to further boost the growth of the market during the forecast period. Moreover, the growing demand for biological products and biological drugs is expected to create lucrative growth during the forecast period. Similarly, increasing presence of established biopharmaceuticals industry and major players in the region is anticipated to boost the growth of the market over the years. Furthermore, increasing investments by pharmaceutical and biopharmaceutical companies along with growing academic and government investments in diagnostic research is expected to further boost the growth of the market during the forecast period. Besides, growing demand for advanced technologies for various activities in the healthcare industry is further expected to create lucrative opportunities for market growth” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.
“Bioprocess Containers Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories), By Application (Upstream Process, Downstream Process, Process Development), By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others) and By Region and Competition”, has evaluated the future growth potential of global Bioprocess Containers market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision-makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the Global Bioprocess Containers market.
Download Free Sample Report – https://www.techsciresearch.com/sample-report.aspx?cid=15113
Related Reports:
Clinical trial outsourcing market
About TechSci Research:
TechSci Research is a research-based management consulting firm providing market research and advisory solutions to its customers worldwide, spanning a range of industries. TechSci Research’s core values are value, integrity and insight. Led by a team of dynamic industry experts, TechSci Research provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, TechSci’s client leads rather than follow market trends. Not bound by legacy, TechSci’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, TechSci Research reports do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
Web: https://www.techsciresearch.com